Treatment of autism
AssigneeSynaptec Development LLC
InventorBonnie M. DAVIS
Life of this patent
Estimating the term…
Loading patent…
AssigneeSynaptec Development LLC
InventorBonnie M. DAVIS
Estimating the term…
Autistic Spectrum Disorders (ASD) are a group of developmental disorders including autistic disorder, Asperger disorder and pervasive developmental disorder not otherwise specified which may be treated by use of a galanthamine analog wherein the hydroxy group of galantamine is replaced by a carbamate, carbonate or ester group and the metboxy group may be replaced by another alkoxy group of from two to six carbon atoms, a hydroxy group, hydrogen, an alkanoyloxy group or 2 to 10 carbon atoms, a benzoyloxy or substituted benzoyloxy group, a carbonate group of 1 to 10 carbon atoms or a carbamate group such as a mono alkyl or dialkyl or an aryl carbamate wherein the alkyl groups or aryl groups contain from 1 to 10 carbons, and the N-methyl group may be replaced by hydrogen, alkyl of 1 to 10 carbon atoms, benzyl, cyclopropylmethyl group or a substituted or unsubstituted benzoyloxy group. Galantamine mon-alkylcarbamates are particularly useful.
A method for treating patients with Autism Spectrum Disorders which comprises administering to a patient in need thereof a therapeutically effective dose of a galanthamine analog wherein
Dependencies are inferred from the claim text.